Jennifer Lovick
Jennifer Lovick/LinkedIn

Jennifer Lovick: August Research Round-Up in Cancer Technology

Jennifer Lovick, Executive Editor of Gold Open Access Journals at Sage, shared a post on LinkedIn:

“Explore the latest research from Technology in Cancer Research and Treatment’s August round-up featuring in-depth studies and reviews.
See all articles published in August.

Featured articles of the month:
Evaluation of Concomitant Imaging Dose in 4D-CBCT Guided Thoracic Radiotherapy
This study shows that imaging doses from 4D-CBCT in thoracic radiotherapy are low and unlikely to impact organ-at-risk dose parameters in 5-fraction treatments.

Cost-Efficient Early Diagnostic Tool for Lung Cancer: Explainable AI in Clinical Systems
This study introduces an explainable AI model using routine clinical data to improve early lung cancer diagnosis, boosting rare case detection by over 50%.

The Role of Whole-Body MRI in Patients with Lymphoma: A Narrative Review
This review highlights whole-body MRI as a radiation-free alternative for staging and monitoring lymphoma, especially valuable for young and pregnant patients.

Predicting the Efficacy of Neoadjuvant Chemotherapy Combined with Immunotherapy for Esophageal Squamous Cell Carcinoma via Enhanced CT Radiomics Combined with Clinical Features
This study shows that combining enhanced CT radiomics with clinical data improves prediction of treatment response in esophageal squamous cell carcinoma patients receiving chemoimmunotherapy.

A Lightweight Dual-Output Vision Transformer for Enhanced Lung Nodule Classification Using CT Images
This study evaluates a lightweight dual-output vision transformer that accurately classifies lung nodules across multiple CT datasets, showing strong potential for clinical use.

Harnessing the Gut Microbiome in Cancer Immunotherapy: Mechanisms, Challenges, and Routes to Personalized Medicine—A Systematic Review
This review highlights how probiotics can enhance cancer immunotherapy by modulating immune responses via the gut microbiome, paving the way for personalized treatment strategies.”

More from Jennifer Lovick on OncoDaily.